Evaluation of Naturally Occurring HIF-1 Inhibitors for Pulmonary Arterial Hypertension

Midori A. Arai, Kota Sakuraba, Yoshinori Makita, Yasumasa Hara, Masami Ishibashi

研究成果: Article査読

2 被引用数 (Scopus)

抄録

Pulmonary arterial hypertension (PAH) is a rare and severe progressive disorder characterized by high pulmonary artery pressure. Chronic hypoxia causes a metabolic disorder and the Warburg effect in pulmonary arterial smooth muscle cells (PASMCs). Pyruvate dehydrogenase kinase 1 (PDK1) is a key enzyme in Warburg effect increased by hypoxia-inducible factor (HIF-1). We constructed a cell-based luciferase assay system for HIF-1 inhibitors. Using this system, six HIF-1 inhibitors were identified. Among these inhibitors, the effect of tagitinin C (1) on PASMC was investigated. Tagitinin C (1) clearly decreased the amount of HIF-1β and the HIF-1 target PDK1. This result indicates that HIF-1 inhibitors effectively decrease PDK1 activity, which is a cause of the metabolic disorder and Warburg effect observed in PASMCs. Identifying naturally occurring HIF-1 inhibitors could provide novel insights into the development of PAH medications.

本文言語English
ページ(範囲)2799-2804
ページ数6
ジャーナルChemBioChem
22
18
DOI
出版ステータスPublished - 2021 9月 14

ASJC Scopus subject areas

  • 生化学
  • 分子医療
  • 分子生物学
  • 有機化学

フィンガープリント

「Evaluation of Naturally Occurring HIF-1 Inhibitors for Pulmonary Arterial Hypertension」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル